遺伝子治療の革命：治療法、画期的進歩、遺伝医学の課題
In February 2025, CHOP administered the world’s first in vivo CRISPR gene therapy to an infant with CPS1 deficiency, as
AI株熱狂：テック大手の好決算が記録的なラリーを牽引、ウォール街はAIに大きく賭ける
Alphabet will raise 2025 AI-related capital spending by $10 billion to $85 billion after strong Q2 profit and cloud reve